Application of predeposit of autologous blood transfusion in lumbar spine surgery: a prospective study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039824

Enrollment

Unknown

Registered

2020-11-11

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar degenerative disease

Interventions

Group A (Control group):Non-PABD

Group A(one week):PABD one week before surgery

Group C (two week):PABD two week before surgery

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who will receive lumbar fusion surgery for lumbar degenerative disease. 2. Pass for the preoperative and anesthesia assessment in impatient management center. 3. Aged 18-70 years. 4. Hgb >= 110g/L. 5. Allogeneic blood transfusion risk score of lumbar fusion surgery: "high risk".

Exclusion criteria

Exclusion criteria: 1. Metastatic diseases of malignant tumor. 2. Infectious diseases. 3. Cardiovascular and cerebrovascular comorbidity such as coronary heart disease and severe aorta stenosis. 4. Critically ill patients. 5. Refuse to participate in this study for any reason.

Design outcomes

Primary

Measure	Time frame
Incidence of allogeneic blood transfusion;Amount of allogeneic blood transfusion;Hgb (before surgery)-Hgb(before discharge);	—

Secondary

Measure	Time frame
Hospital stays after surgery;Incidence of complications (wound infection and hemotoma);Improvement of nerve function;	—

Countries

China

Contacts

Public ContactYun Tian

Peking University Third Hospital

xunanfang@foxmail.com+86 15652374179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026